Update on MIGS: Devices of the Future

On June 25, 2012, after more than a decade of development and clinical evaluation, the iStent (Glaukos Corporation) received FDA approval for the management of mild to moderate openangle glaucoma at the time of cataract surgery. This widely a...

Full Story →